Regeneron, Sanofi begin testing use of Arthritis Drug Kevzara to treat COVID-19 Medical Dialogues Bureau18 March 2020 6:54 AM GMTKevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor.The use of...
Sanofi loses German patent case against Amgen over cholesterol drug Praluent Medical Dialogues Bureau9 Jun 2019 4:00 AM GMTIn the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that Sanof...
Sanofi to pay Regeneron $462 million in revised immuno-oncology deal Farhat Nasim9 Jan 2019 3:45 AM GMTSanofi will pay Regeneron $462 million representing the balance of payments due under their original deal, which covers the Sanofi share of the immuno-...
Novartis posts eye drug data amid play for Eylea's turf Ruby Khatun Khatun14 Nov 2017 4:15 AM GMTZURICH: Novartis's bid to move in on Bayer's and Regeneron's eye-drug turf was buoyed on Friday by data showing patients on the Swiss drugmaker's new...
Regeneron third-quarter profit easily tops Street view on Eylea, Dupixent sales Ruby Khatun Khatun11 Nov 2017 4:00 AM GMTRegeneron Pharmaceuticals Inc on Wednesday reported third-quarter profit that sailed past Wall Street estimates on the strength of increased demand...
DBV Technologies peanut allergy drug fails key study Ruby Khatun Khatun23 Oct 2017 3:45 AM GMTDBV Technologies SA said on Friday its peanut allergy treatment did not meet the main goal in a highly anticipated late-stage study, sending its...
Regeneron, Sanofi asthma drug data fails to excite investors Ruby Khatun Khatun13 Sep 2017 8:12 AM GMTPARIS: Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor...
